Global Custom Assays Market

Custom Assays Comprehensive Study by Type (Activity Assays, Competitive Assays, Elisa Assays, Sandwich Assays, Screening Assays, Conjugation Assay, Others), Application (Academic and Research Institutes, Life Science Industries, Biotechnology Companies, Diagnostic Centers, Contract Research Organizations, Food and Beverage Companies), Technology (Flow Cytometry, Membrane Based/Planar Assays, Suspension/ Bead Based Assays, Others) Players and Region - Global Market Outlook to 2027

Custom Assays Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Custom Assays Market Scope
The custom assay is provided by assay kits manufacturers to customers. Custom arrays help in providing easy solutions to industrial and academic laboratories for the determination of different biological analyses such as proteins, antibodies, enzymes and many more. This market is growing significantly in emerging countries such as Japan, India, and others due to increasing numbers of research institutes.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledPromega Corporation (United States), Bioassay Systems (United States), QIAGEN N.V (Germany), Sigma-Aldrich Inc. (United States), Thermo Fisher Scientific Inc. (United States), R & D Syatems Inc. (United States), BioAuxilium Research Inc. (Canada), Fluidigm (United States), Luminex Corporation (United States) and F. Hoffmann-La Roche AG (Switzerland)
CAGR%


In This Market Major Players Are Adopting Initiatives to Achieve Organic and Inorganic Growth Strategies. Which Includes Enhancing Global Reach And Expanding Product Portfolio By Doing Merger & Acquisitions And Collaborations. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Custom Assays market throughout the predicted period.

Promega Corporation (United States), Bioassay Systems (United States), QIAGEN N.V (Germany), Sigma-Aldrich Inc. (United States), Thermo Fisher Scientific Inc. (United States), R & D Syatems Inc. (United States), BioAuxilium Research Inc. (Canada), Fluidigm (United States), Luminex Corporation (United States) and F. Hoffmann-La Roche AG (Switzerland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Clovis Oncology Inc. (United States), BD Biosciences (United States) and Quansys Bioscience (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Custom Assays market by Type , by Application (Academic and Research Institutes, Life Science Industries, Biotechnology Companies, Diagnostic Centers, Contract Research Organizations and Food and Beverage Companies) and Region with country level break-up.

On the basis of geography, the market of Custom Assays has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2021.

Market Leaders and their expansionary development strategies
In October 2023, PerkinElmer has partnered with Alnylam, a leading developer of RNA interference (RNAi) therapeutics, to develop custom assays for RNAi therapeutics. The partnership will combine PerkinElmer's expertise in assay development and validation with Alnylam's expertise in RNAi therapeutics to create new custom assays for a variety of RNAi therapeutics.
In October 2023, Thermo Fisher Scientific, a leading provider of scientific instruments and consumables, has launched a new custom assay development platform called SureSight Custom Assays. The platform is designed to help researchers develop and validate custom assays more quickly and efficiently.


Influencing Trend:
The increasing demand for multiplex assays and The growing demand for personalized medicine

Market Growth Drivers:
Rise In Research and Development Activities in Life Science and Biotechnology Industry, Increasing Number of Academic and Research Institutes across the Globe and Growing Demand for Tissue Diagnostic and Cell Based Diagnostics for Cancer, HIV, and Infectious Diseases

Challenges:
Optimization and Standardization

Restraints:
High cost of custom assays and Complexity of custom assay development

Opportunities:
The Emergence of the Biochip Technology Creating Strong Opportunities for the Service Providers in the Market

Key Target Audience
Custom Assays Manufacturers, Research Institutes, Government Bodies, End Users and Others

Report Objectives / Segmentation Covered

By Type
  • Activity Assays
  • Competitive Assays
  • Elisa Assays
  • Sandwich Assays
  • Screening Assays
  • Conjugation Assay
  • Others
By Application
  • Academic and Research Institutes
  • Life Science Industries
  • Biotechnology Companies
  • Diagnostic Centers
  • Contract Research Organizations
  • Food and Beverage Companies
By Technology
  • Flow Cytometry
  • Membrane Based/Planar Assays
  • Suspension/ Bead Based Assays
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise In Research and Development Activities in Life Science and Biotechnology Industry
      • 3.2.2. Increasing Number of Academic and Research Institutes across the Globe
      • 3.2.3. Growing Demand for Tissue Diagnostic and Cell Based Diagnostics for Cancer, HIV, and Infectious Diseases
    • 3.3. Market Challenges
      • 3.3.1. Optimization and Standardization
    • 3.4. Market Trends
      • 3.4.1. The increasing demand for multiplex assays
      • 3.4.2. The growing demand for personalized medicine
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Custom Assays, by Type, Application, Technology and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Custom Assays (Value)
      • 5.2.1. Global Custom Assays by: Type (Value)
        • 5.2.1.1. Activity Assays
        • 5.2.1.2. Competitive Assays
        • 5.2.1.3. Elisa Assays
        • 5.2.1.4. Sandwich Assays
        • 5.2.1.5. Screening Assays
        • 5.2.1.6. Conjugation Assay
        • 5.2.1.7. Others
      • 5.2.2. Global Custom Assays by: Application (Value)
        • 5.2.2.1. Academic and Research Institutes
        • 5.2.2.2. Life Science Industries
        • 5.2.2.3. Biotechnology Companies
        • 5.2.2.4. Diagnostic Centers
        • 5.2.2.5. Contract Research Organizations
        • 5.2.2.6. Food and Beverage Companies
      • 5.2.3. Global Custom Assays by: Technology (Value)
        • 5.2.3.1. Flow Cytometry
        • 5.2.3.2. Membrane Based/Planar Assays
        • 5.2.3.3. Suspension/ Bead Based Assays
        • 5.2.3.4. Others
      • 5.2.4. Global Custom Assays Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Custom Assays: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Promega Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bioassay Systems (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. QIAGEN N.V (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sigma-Aldrich Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Thermo Fisher Scientific Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. R & D Syatems Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BioAuxilium Research Inc. (Canada)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Fluidigm (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Luminex Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Custom Assays Sale, by Type, Application, Technology and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Custom Assays (Value)
      • 7.2.1. Global Custom Assays by: Type (Value)
        • 7.2.1.1. Activity Assays
        • 7.2.1.2. Competitive Assays
        • 7.2.1.3. Elisa Assays
        • 7.2.1.4. Sandwich Assays
        • 7.2.1.5. Screening Assays
        • 7.2.1.6. Conjugation Assay
        • 7.2.1.7. Others
      • 7.2.2. Global Custom Assays by: Application (Value)
        • 7.2.2.1. Academic and Research Institutes
        • 7.2.2.2. Life Science Industries
        • 7.2.2.3. Biotechnology Companies
        • 7.2.2.4. Diagnostic Centers
        • 7.2.2.5. Contract Research Organizations
        • 7.2.2.6. Food and Beverage Companies
      • 7.2.3. Global Custom Assays by: Technology (Value)
        • 7.2.3.1. Flow Cytometry
        • 7.2.3.2. Membrane Based/Planar Assays
        • 7.2.3.3. Suspension/ Bead Based Assays
        • 7.2.3.4. Others
      • 7.2.4. Global Custom Assays Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Custom Assays: by Type(USD Million)
  • Table 2. Custom Assays Activity Assays , by Region USD Million (2016-2021)
  • Table 3. Custom Assays Competitive Assays , by Region USD Million (2016-2021)
  • Table 4. Custom Assays Elisa Assays , by Region USD Million (2016-2021)
  • Table 5. Custom Assays Sandwich Assays , by Region USD Million (2016-2021)
  • Table 6. Custom Assays Screening Assays , by Region USD Million (2016-2021)
  • Table 7. Custom Assays Conjugation Assay , by Region USD Million (2016-2021)
  • Table 8. Custom Assays Others , by Region USD Million (2016-2021)
  • Table 9. Custom Assays: by Application(USD Million)
  • Table 10. Custom Assays Academic and Research Institutes , by Region USD Million (2016-2021)
  • Table 11. Custom Assays Life Science Industries , by Region USD Million (2016-2021)
  • Table 12. Custom Assays Biotechnology Companies , by Region USD Million (2016-2021)
  • Table 13. Custom Assays Diagnostic Centers , by Region USD Million (2016-2021)
  • Table 14. Custom Assays Contract Research Organizations , by Region USD Million (2016-2021)
  • Table 15. Custom Assays Food and Beverage Companies , by Region USD Million (2016-2021)
  • Table 16. Custom Assays: by Technology(USD Million)
  • Table 17. Custom Assays Flow Cytometry , by Region USD Million (2016-2021)
  • Table 18. Custom Assays Membrane Based/Planar Assays , by Region USD Million (2016-2021)
  • Table 19. Custom Assays Suspension/ Bead Based Assays , by Region USD Million (2016-2021)
  • Table 20. Custom Assays Others , by Region USD Million (2016-2021)
  • Table 21. South America Custom Assays, by Country USD Million (2016-2021)
  • Table 22. South America Custom Assays, by Type USD Million (2016-2021)
  • Table 23. South America Custom Assays, by Application USD Million (2016-2021)
  • Table 24. South America Custom Assays, by Technology USD Million (2016-2021)
  • Table 25. Brazil Custom Assays, by Type USD Million (2016-2021)
  • Table 26. Brazil Custom Assays, by Application USD Million (2016-2021)
  • Table 27. Brazil Custom Assays, by Technology USD Million (2016-2021)
  • Table 28. Argentina Custom Assays, by Type USD Million (2016-2021)
  • Table 29. Argentina Custom Assays, by Application USD Million (2016-2021)
  • Table 30. Argentina Custom Assays, by Technology USD Million (2016-2021)
  • Table 31. Rest of South America Custom Assays, by Type USD Million (2016-2021)
  • Table 32. Rest of South America Custom Assays, by Application USD Million (2016-2021)
  • Table 33. Rest of South America Custom Assays, by Technology USD Million (2016-2021)
  • Table 34. Asia Pacific Custom Assays, by Country USD Million (2016-2021)
  • Table 35. Asia Pacific Custom Assays, by Type USD Million (2016-2021)
  • Table 36. Asia Pacific Custom Assays, by Application USD Million (2016-2021)
  • Table 37. Asia Pacific Custom Assays, by Technology USD Million (2016-2021)
  • Table 38. China Custom Assays, by Type USD Million (2016-2021)
  • Table 39. China Custom Assays, by Application USD Million (2016-2021)
  • Table 40. China Custom Assays, by Technology USD Million (2016-2021)
  • Table 41. Japan Custom Assays, by Type USD Million (2016-2021)
  • Table 42. Japan Custom Assays, by Application USD Million (2016-2021)
  • Table 43. Japan Custom Assays, by Technology USD Million (2016-2021)
  • Table 44. India Custom Assays, by Type USD Million (2016-2021)
  • Table 45. India Custom Assays, by Application USD Million (2016-2021)
  • Table 46. India Custom Assays, by Technology USD Million (2016-2021)
  • Table 47. South Korea Custom Assays, by Type USD Million (2016-2021)
  • Table 48. South Korea Custom Assays, by Application USD Million (2016-2021)
  • Table 49. South Korea Custom Assays, by Technology USD Million (2016-2021)
  • Table 50. Taiwan Custom Assays, by Type USD Million (2016-2021)
  • Table 51. Taiwan Custom Assays, by Application USD Million (2016-2021)
  • Table 52. Taiwan Custom Assays, by Technology USD Million (2016-2021)
  • Table 53. Australia Custom Assays, by Type USD Million (2016-2021)
  • Table 54. Australia Custom Assays, by Application USD Million (2016-2021)
  • Table 55. Australia Custom Assays, by Technology USD Million (2016-2021)
  • Table 56. Rest of Asia-Pacific Custom Assays, by Type USD Million (2016-2021)
  • Table 57. Rest of Asia-Pacific Custom Assays, by Application USD Million (2016-2021)
  • Table 58. Rest of Asia-Pacific Custom Assays, by Technology USD Million (2016-2021)
  • Table 59. Europe Custom Assays, by Country USD Million (2016-2021)
  • Table 60. Europe Custom Assays, by Type USD Million (2016-2021)
  • Table 61. Europe Custom Assays, by Application USD Million (2016-2021)
  • Table 62. Europe Custom Assays, by Technology USD Million (2016-2021)
  • Table 63. Germany Custom Assays, by Type USD Million (2016-2021)
  • Table 64. Germany Custom Assays, by Application USD Million (2016-2021)
  • Table 65. Germany Custom Assays, by Technology USD Million (2016-2021)
  • Table 66. France Custom Assays, by Type USD Million (2016-2021)
  • Table 67. France Custom Assays, by Application USD Million (2016-2021)
  • Table 68. France Custom Assays, by Technology USD Million (2016-2021)
  • Table 69. Italy Custom Assays, by Type USD Million (2016-2021)
  • Table 70. Italy Custom Assays, by Application USD Million (2016-2021)
  • Table 71. Italy Custom Assays, by Technology USD Million (2016-2021)
  • Table 72. United Kingdom Custom Assays, by Type USD Million (2016-2021)
  • Table 73. United Kingdom Custom Assays, by Application USD Million (2016-2021)
  • Table 74. United Kingdom Custom Assays, by Technology USD Million (2016-2021)
  • Table 75. Netherlands Custom Assays, by Type USD Million (2016-2021)
  • Table 76. Netherlands Custom Assays, by Application USD Million (2016-2021)
  • Table 77. Netherlands Custom Assays, by Technology USD Million (2016-2021)
  • Table 78. Rest of Europe Custom Assays, by Type USD Million (2016-2021)
  • Table 79. Rest of Europe Custom Assays, by Application USD Million (2016-2021)
  • Table 80. Rest of Europe Custom Assays, by Technology USD Million (2016-2021)
  • Table 81. MEA Custom Assays, by Country USD Million (2016-2021)
  • Table 82. MEA Custom Assays, by Type USD Million (2016-2021)
  • Table 83. MEA Custom Assays, by Application USD Million (2016-2021)
  • Table 84. MEA Custom Assays, by Technology USD Million (2016-2021)
  • Table 85. Middle East Custom Assays, by Type USD Million (2016-2021)
  • Table 86. Middle East Custom Assays, by Application USD Million (2016-2021)
  • Table 87. Middle East Custom Assays, by Technology USD Million (2016-2021)
  • Table 88. Africa Custom Assays, by Type USD Million (2016-2021)
  • Table 89. Africa Custom Assays, by Application USD Million (2016-2021)
  • Table 90. Africa Custom Assays, by Technology USD Million (2016-2021)
  • Table 91. North America Custom Assays, by Country USD Million (2016-2021)
  • Table 92. North America Custom Assays, by Type USD Million (2016-2021)
  • Table 93. North America Custom Assays, by Application USD Million (2016-2021)
  • Table 94. North America Custom Assays, by Technology USD Million (2016-2021)
  • Table 95. United States Custom Assays, by Type USD Million (2016-2021)
  • Table 96. United States Custom Assays, by Application USD Million (2016-2021)
  • Table 97. United States Custom Assays, by Technology USD Million (2016-2021)
  • Table 98. Canada Custom Assays, by Type USD Million (2016-2021)
  • Table 99. Canada Custom Assays, by Application USD Million (2016-2021)
  • Table 100. Canada Custom Assays, by Technology USD Million (2016-2021)
  • Table 101. Mexico Custom Assays, by Type USD Million (2016-2021)
  • Table 102. Mexico Custom Assays, by Application USD Million (2016-2021)
  • Table 103. Mexico Custom Assays, by Technology USD Million (2016-2021)
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Custom Assays: by Type(USD Million)
  • Table 115. Custom Assays Activity Assays , by Region USD Million (2022-2027)
  • Table 116. Custom Assays Competitive Assays , by Region USD Million (2022-2027)
  • Table 117. Custom Assays Elisa Assays , by Region USD Million (2022-2027)
  • Table 118. Custom Assays Sandwich Assays , by Region USD Million (2022-2027)
  • Table 119. Custom Assays Screening Assays , by Region USD Million (2022-2027)
  • Table 120. Custom Assays Conjugation Assay , by Region USD Million (2022-2027)
  • Table 121. Custom Assays Others , by Region USD Million (2022-2027)
  • Table 122. Custom Assays: by Application(USD Million)
  • Table 123. Custom Assays Academic and Research Institutes , by Region USD Million (2022-2027)
  • Table 124. Custom Assays Life Science Industries , by Region USD Million (2022-2027)
  • Table 125. Custom Assays Biotechnology Companies , by Region USD Million (2022-2027)
  • Table 126. Custom Assays Diagnostic Centers , by Region USD Million (2022-2027)
  • Table 127. Custom Assays Contract Research Organizations , by Region USD Million (2022-2027)
  • Table 128. Custom Assays Food and Beverage Companies , by Region USD Million (2022-2027)
  • Table 129. Custom Assays: by Technology(USD Million)
  • Table 130. Custom Assays Flow Cytometry , by Region USD Million (2022-2027)
  • Table 131. Custom Assays Membrane Based/Planar Assays , by Region USD Million (2022-2027)
  • Table 132. Custom Assays Suspension/ Bead Based Assays , by Region USD Million (2022-2027)
  • Table 133. Custom Assays Others , by Region USD Million (2022-2027)
  • Table 134. South America Custom Assays, by Country USD Million (2022-2027)
  • Table 135. South America Custom Assays, by Type USD Million (2022-2027)
  • Table 136. South America Custom Assays, by Application USD Million (2022-2027)
  • Table 137. South America Custom Assays, by Technology USD Million (2022-2027)
  • Table 138. Brazil Custom Assays, by Type USD Million (2022-2027)
  • Table 139. Brazil Custom Assays, by Application USD Million (2022-2027)
  • Table 140. Brazil Custom Assays, by Technology USD Million (2022-2027)
  • Table 141. Argentina Custom Assays, by Type USD Million (2022-2027)
  • Table 142. Argentina Custom Assays, by Application USD Million (2022-2027)
  • Table 143. Argentina Custom Assays, by Technology USD Million (2022-2027)
  • Table 144. Rest of South America Custom Assays, by Type USD Million (2022-2027)
  • Table 145. Rest of South America Custom Assays, by Application USD Million (2022-2027)
  • Table 146. Rest of South America Custom Assays, by Technology USD Million (2022-2027)
  • Table 147. Asia Pacific Custom Assays, by Country USD Million (2022-2027)
  • Table 148. Asia Pacific Custom Assays, by Type USD Million (2022-2027)
  • Table 149. Asia Pacific Custom Assays, by Application USD Million (2022-2027)
  • Table 150. Asia Pacific Custom Assays, by Technology USD Million (2022-2027)
  • Table 151. China Custom Assays, by Type USD Million (2022-2027)
  • Table 152. China Custom Assays, by Application USD Million (2022-2027)
  • Table 153. China Custom Assays, by Technology USD Million (2022-2027)
  • Table 154. Japan Custom Assays, by Type USD Million (2022-2027)
  • Table 155. Japan Custom Assays, by Application USD Million (2022-2027)
  • Table 156. Japan Custom Assays, by Technology USD Million (2022-2027)
  • Table 157. India Custom Assays, by Type USD Million (2022-2027)
  • Table 158. India Custom Assays, by Application USD Million (2022-2027)
  • Table 159. India Custom Assays, by Technology USD Million (2022-2027)
  • Table 160. South Korea Custom Assays, by Type USD Million (2022-2027)
  • Table 161. South Korea Custom Assays, by Application USD Million (2022-2027)
  • Table 162. South Korea Custom Assays, by Technology USD Million (2022-2027)
  • Table 163. Taiwan Custom Assays, by Type USD Million (2022-2027)
  • Table 164. Taiwan Custom Assays, by Application USD Million (2022-2027)
  • Table 165. Taiwan Custom Assays, by Technology USD Million (2022-2027)
  • Table 166. Australia Custom Assays, by Type USD Million (2022-2027)
  • Table 167. Australia Custom Assays, by Application USD Million (2022-2027)
  • Table 168. Australia Custom Assays, by Technology USD Million (2022-2027)
  • Table 169. Rest of Asia-Pacific Custom Assays, by Type USD Million (2022-2027)
  • Table 170. Rest of Asia-Pacific Custom Assays, by Application USD Million (2022-2027)
  • Table 171. Rest of Asia-Pacific Custom Assays, by Technology USD Million (2022-2027)
  • Table 172. Europe Custom Assays, by Country USD Million (2022-2027)
  • Table 173. Europe Custom Assays, by Type USD Million (2022-2027)
  • Table 174. Europe Custom Assays, by Application USD Million (2022-2027)
  • Table 175. Europe Custom Assays, by Technology USD Million (2022-2027)
  • Table 176. Germany Custom Assays, by Type USD Million (2022-2027)
  • Table 177. Germany Custom Assays, by Application USD Million (2022-2027)
  • Table 178. Germany Custom Assays, by Technology USD Million (2022-2027)
  • Table 179. France Custom Assays, by Type USD Million (2022-2027)
  • Table 180. France Custom Assays, by Application USD Million (2022-2027)
  • Table 181. France Custom Assays, by Technology USD Million (2022-2027)
  • Table 182. Italy Custom Assays, by Type USD Million (2022-2027)
  • Table 183. Italy Custom Assays, by Application USD Million (2022-2027)
  • Table 184. Italy Custom Assays, by Technology USD Million (2022-2027)
  • Table 185. United Kingdom Custom Assays, by Type USD Million (2022-2027)
  • Table 186. United Kingdom Custom Assays, by Application USD Million (2022-2027)
  • Table 187. United Kingdom Custom Assays, by Technology USD Million (2022-2027)
  • Table 188. Netherlands Custom Assays, by Type USD Million (2022-2027)
  • Table 189. Netherlands Custom Assays, by Application USD Million (2022-2027)
  • Table 190. Netherlands Custom Assays, by Technology USD Million (2022-2027)
  • Table 191. Rest of Europe Custom Assays, by Type USD Million (2022-2027)
  • Table 192. Rest of Europe Custom Assays, by Application USD Million (2022-2027)
  • Table 193. Rest of Europe Custom Assays, by Technology USD Million (2022-2027)
  • Table 194. MEA Custom Assays, by Country USD Million (2022-2027)
  • Table 195. MEA Custom Assays, by Type USD Million (2022-2027)
  • Table 196. MEA Custom Assays, by Application USD Million (2022-2027)
  • Table 197. MEA Custom Assays, by Technology USD Million (2022-2027)
  • Table 198. Middle East Custom Assays, by Type USD Million (2022-2027)
  • Table 199. Middle East Custom Assays, by Application USD Million (2022-2027)
  • Table 200. Middle East Custom Assays, by Technology USD Million (2022-2027)
  • Table 201. Africa Custom Assays, by Type USD Million (2022-2027)
  • Table 202. Africa Custom Assays, by Application USD Million (2022-2027)
  • Table 203. Africa Custom Assays, by Technology USD Million (2022-2027)
  • Table 204. North America Custom Assays, by Country USD Million (2022-2027)
  • Table 205. North America Custom Assays, by Type USD Million (2022-2027)
  • Table 206. North America Custom Assays, by Application USD Million (2022-2027)
  • Table 207. North America Custom Assays, by Technology USD Million (2022-2027)
  • Table 208. United States Custom Assays, by Type USD Million (2022-2027)
  • Table 209. United States Custom Assays, by Application USD Million (2022-2027)
  • Table 210. United States Custom Assays, by Technology USD Million (2022-2027)
  • Table 211. Canada Custom Assays, by Type USD Million (2022-2027)
  • Table 212. Canada Custom Assays, by Application USD Million (2022-2027)
  • Table 213. Canada Custom Assays, by Technology USD Million (2022-2027)
  • Table 214. Mexico Custom Assays, by Type USD Million (2022-2027)
  • Table 215. Mexico Custom Assays, by Application USD Million (2022-2027)
  • Table 216. Mexico Custom Assays, by Technology USD Million (2022-2027)
  • Table 217. Research Programs/Design for This Report
  • Table 218. Key Data Information from Secondary Sources
  • Table 219. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Custom Assays: by Type USD Million (2016-2021)
  • Figure 5. Global Custom Assays: by Application USD Million (2016-2021)
  • Figure 6. Global Custom Assays: by Technology USD Million (2016-2021)
  • Figure 7. South America Custom Assays Share (%), by Country
  • Figure 8. Asia Pacific Custom Assays Share (%), by Country
  • Figure 9. Europe Custom Assays Share (%), by Country
  • Figure 10. MEA Custom Assays Share (%), by Country
  • Figure 11. North America Custom Assays Share (%), by Country
  • Figure 12. Global Custom Assays share by Players 2021 (%)
  • Figure 13. Global Custom Assays share by Players (Top 3) 2021(%)
  • Figure 14. Global Custom Assays share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Promega Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 17. Promega Corporation (United States) Revenue: by Geography 2021
  • Figure 18. Bioassay Systems (United States) Revenue, Net Income and Gross profit
  • Figure 19. Bioassay Systems (United States) Revenue: by Geography 2021
  • Figure 20. QIAGEN N.V (Germany) Revenue, Net Income and Gross profit
  • Figure 21. QIAGEN N.V (Germany) Revenue: by Geography 2021
  • Figure 22. Sigma-Aldrich Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Sigma-Aldrich Inc. (United States) Revenue: by Geography 2021
  • Figure 24. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2021
  • Figure 26. R & D Syatems Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. R & D Syatems Inc. (United States) Revenue: by Geography 2021
  • Figure 28. BioAuxilium Research Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 29. BioAuxilium Research Inc. (Canada) Revenue: by Geography 2021
  • Figure 30. Fluidigm (United States) Revenue, Net Income and Gross profit
  • Figure 31. Fluidigm (United States) Revenue: by Geography 2021
  • Figure 32. Luminex Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. Luminex Corporation (United States) Revenue: by Geography 2021
  • Figure 34. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 35. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2021
  • Figure 36. Global Custom Assays: by Type USD Million (2022-2027)
  • Figure 37. Global Custom Assays: by Application USD Million (2022-2027)
  • Figure 38. Global Custom Assays: by Technology USD Million (2022-2027)
  • Figure 39. South America Custom Assays Share (%), by Country
  • Figure 40. Asia Pacific Custom Assays Share (%), by Country
  • Figure 41. Europe Custom Assays Share (%), by Country
  • Figure 42. MEA Custom Assays Share (%), by Country
  • Figure 43. North America Custom Assays Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Promega Corporation (United States)
  • Bioassay Systems (United States)
  • QIAGEN N.V (Germany)
  • Sigma-Aldrich Inc. (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • R & D Syatems Inc. (United States)
  • BioAuxilium Research Inc. (Canada)
  • Fluidigm (United States)
  • Luminex Corporation (United States)
  • F. Hoffmann-La Roche AG (Switzerland)
Additional players considered in the study are as follows:
Clovis Oncology Inc. (United States) , BD Biosciences (United States) , Quansys Bioscience (United States)
Select User Access Type

Key Highlights of Report


Nov 2023 217 Pages 74 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Custom Assays Market Quantitative research analysis
Global Custom Assays Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Custom Assays Market are by type [Activity Assays, Competitive Assays, Elisa Assays, Sandwich Assays, Screening Assays, Conjugation Assay and Others], by end use application [Academic and Research Institutes, Life Science Industries, Biotechnology Companies, Diagnostic Centers, Contract Research Organizations and Food and Beverage Companies].
The Custom Assays Market is gaining popularity and expected to see strong valuation by 2027.
  • Rise In Research and Development Activities in Life Science and Biotechnology Industry
  • Increasing Number of Academic and Research Institutes across the Globe
  • Growing Demand for Tissue Diagnostic and Cell Based Diagnostics for Cancer, HIV, and Infectious Diseases

Know More About Global Custom Assays Market Report?

Have a Query? Click Here

Other Related Reports

Oligonucleotides Comprehensive Study by Type (DNA Oligos, RNA Oligos), Application (Gene expression experiments,, Probes for microarrays, Antisense technologies, In situ hybridization, Drug carriers)...
$ 3650
Monoclonal Mouse Antibody Comprehensive Study by Type (IgM, IgG, IgA, Others), Application (Therapeutic, Research, Diagnostic), Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, Infecti...
$ 3450
Flow Cytometers Comprehensive Study by Application (Oncology, Drug Discovery, Disease Diagnosis, Stem Cell Therapy, Organ Transplantation, Hematology), Technology (Cell-based, Bead-based), End use (H...
$ 3650
Porcine Serum Comprehensive Study by Application (Mycoplasmas and Viruses Culture, Lymphocytes Culture, Vaccine Production, Others), Packaging (100 mL, 500 mL, 1000 mL, Others) Players and Region - G...
$ 3500
Antimicrobial Packaging Comprehensive Study by Type (Pouches, Carton Packages, Bags, Trays, Cups & Lids, Others), Application (Food & Beverages, Personal Care, Healthcare, Others), Antimicrobial Agen...
$ 3650
Podophyllotoxin Comprehensive Study by Type (Purity 95%, Purity 98%, Other), Application (Chemical Reagents, Pharmaceutical Intermediates, Other) Players and Region - Global Market Outlook to 2026
$ 3500